{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(6)"],"submitter":["Oh TJ"],"pubmed_abstract":["Bronchoscopy is a frequently used initial diagnostic procedure for patients with suspected lung cancer (LC). Cytological examinations of bronchial washing (BW) samples obtained during bronchoscopy often yield inconclusive results regarding LC diagnosis. The present study aimed to identify molecular biomarkers as a non-invasive method for LC diagnosis. Aberrant DNA methylation is used as a useful biomarker for LC. Therefore, microarray-based methylation profiling analyses on 13 patient-matched tumor tissues at stages I-III vs. non-tumor tissues were performed, and a group of highly differentially methylated genes was identified. A subsequent analysis using bisulfite-pyrosequencing with additional tissues and cell lines revealed six methylated genes [ADAM metallopeptidase with thrombospondin"],"journal":["Oncology letters"],"pagination":["246"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11024764"],"repository":["biostudies-literature"],"pubmed_title":["Identification and validation of <i>PCDHGA12</i> and <i>PRRX1</i> methylation for detecting lung cancer in bronchial washing sample."],"pmcid":["PMC11024764"],"pubmed_authors":["Lee MH","Jang S","Oh TJ","Woo MA","Son JW","Kim SJ","Jeong IB","An S"],"additional_accession":[]},"is_claimable":false,"name":"Identification and validation of <i>PCDHGA12</i> and <i>PRRX1</i> methylation for detecting lung cancer in bronchial washing sample.","description":"Bronchoscopy is a frequently used initial diagnostic procedure for patients with suspected lung cancer (LC). Cytological examinations of bronchial washing (BW) samples obtained during bronchoscopy often yield inconclusive results regarding LC diagnosis. The present study aimed to identify molecular biomarkers as a non-invasive method for LC diagnosis. Aberrant DNA methylation is used as a useful biomarker for LC. Therefore, microarray-based methylation profiling analyses on 13 patient-matched tumor tissues at stages I-III vs. non-tumor tissues were performed, and a group of highly differentially methylated genes was identified. A subsequent analysis using bisulfite-pyrosequencing with additional tissues and cell lines revealed six methylated genes [ADAM metallopeptidase with thrombospondin","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jun","modification":"2026-06-01T09:19:44.651Z","creation":"2026-04-08T11:03:15.183Z"},"accession":"S-EPMC11024764","cross_references":{"pubmed":["38638845"],"doi":["10.3892/ol.2024.14379"]}}